These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Gene Therapy for ALS-A Perspective. Cappella M; Ciotti C; Cohen-Tannoudji M; Biferi MG Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500113 [TBL] [Abstract][Full Text] [Related]
30. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346 [TBL] [Abstract][Full Text] [Related]
31. Profiling tofersen as a treatment of superoxide dismutase 1 amyotrophic lateral sclerosis. Oliveira Santos M; de Carvalho M Expert Rev Neurother; 2024 Jun; 24(6):549-553. PubMed ID: 38758193 [TBL] [Abstract][Full Text] [Related]
32. DNA Editing for Amyotrophic Lateral Sclerosis: Leading Off First Base. Cunningham TJ; Fisher E; Fratta P; Gilthorpe JD CRISPR J; 2020 Apr; 3(2):75-77. PubMed ID: 32315228 [No Abstract] [Full Text] [Related]
33. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Lagier-Tourenne C; Baughn M; Rigo F; Sun S; Liu P; Li HR; Jiang J; Watt AT; Chun S; Katz M; Qiu J; Sun Y; Ling SC; Zhu Q; Polymenidou M; Drenner K; Artates JW; McAlonis-Downes M; Markmiller S; Hutt KR; Pizzo DP; Cady J; Harms MB; Baloh RH; Vandenberg SR; Yeo GW; Fu XD; Bennett CF; Cleveland DW; Ravits J Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4530-9. PubMed ID: 24170860 [TBL] [Abstract][Full Text] [Related]
38. Progranulin does not affect motor neuron degeneration in mutant SOD1 mice and rats. Herdewyn S; De Muynck L; Van Den Bosch L; Robberecht W; Van Damme P Neurobiol Aging; 2013 Oct; 34(10):2302-3. PubMed ID: 23608112 [TBL] [Abstract][Full Text] [Related]